Clinical Trial Update: Outcomes of Patients After Allo-HSCT With Decitabine and NAC [Phase 3]

View source ↗

Summary

Phase 3 trial update on outcomes after allogeneic hematopoietic stem cell transplantation using decitabine and NAC for engraftment failure and relapse, with GVH…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disease After Allogeneic Hematopoietic Stem Cell Transplantation
• Engraftment Failure
• Graft-versus-host Disease

Drugs mentioned

• Decitabine (Decitabine)
• NAC

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Engraft Failure, Relapse | Phase 3 | Status: UNKNOWN